These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 20810512

  • 1. Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension.
    Rosato E, Molinaro I, Borghese F, Rossi C, Pisarri S, Salsano F.
    J Rheumatol; 2010 Dec; 37(12):2531-9. PubMed ID: 20810512
    [Abstract] [Full Text] [Related]

  • 2. Laser Doppler perfusion imaging is useful in the study of Raynaud's phenomenon and improves the capillaroscopic diagnosis.
    Rosato E, Borghese F, Pisarri S, Salsano F.
    J Rheumatol; 2009 Oct; 36(10):2257-63. PubMed ID: 19684154
    [Abstract] [Full Text] [Related]

  • 3. Laser Doppler perfusion imaging in systemic sclerosis impaired response to cold stimulation involves digits and hand dorsum.
    Rosato E, Rossi C, Molinaro I, Giovannetti A, Pisarri S, Salsano F.
    Rheumatology (Oxford); 2011 Sep; 50(9):1654-8. PubMed ID: 21622523
    [Abstract] [Full Text] [Related]

  • 4. The combination of laser Doppler perfusion imaging and photoplethysmography is useful in the characterization of scleroderma and primary Raynaud's phenomenon.
    Rosato E, Molinaro I, Rossi C, Pisarri S, Salsano F.
    Scand J Rheumatol; 2011 Sep; 40(4):292-8. PubMed ID: 21338324
    [Abstract] [Full Text] [Related]

  • 5. In systemic sclerosis skin perfusion of hands is reduced and may predict the occurrence of new digital ulcers.
    Barbano B, Marra AM, Quarta S, Gigante A, Barilaro G, Gasperini ML, Rosato E.
    Microvasc Res; 2017 Mar; 110():1-4. PubMed ID: 27838313
    [Abstract] [Full Text] [Related]

  • 6. Blood flow in the hands of a predefined homogeneous systemic sclerosis population: the presence of digital ulcers and the improvement with bosentan.
    Meijs J, Voskuyl AE, Bloemsaat-Minekus JP, Vonk MC.
    Rheumatology (Oxford); 2015 Feb; 54(2):262-9. PubMed ID: 25150178
    [Abstract] [Full Text] [Related]

  • 7. The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension.
    Giannelli G, Iannone F, Marinosci F, Lapadula G, Antonaci S.
    Curr Med Res Opin; 2005 Mar; 21(3):327-32. PubMed ID: 15811199
    [Abstract] [Full Text] [Related]

  • 8. Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis.
    Gaillard-Bigot F, Roustit M, Blaise S, Gabin M, Cracowski C, Seinturier C, Imbert B, Carpentier P, Cracowski JL.
    Microvasc Res; 2014 Jul; 94():90-5. PubMed ID: 24990822
    [Abstract] [Full Text] [Related]

  • 9. Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study.
    Cutolo M, Ferrone C, Pizzorni C, Soldano S, Seriolo B, Sulli A.
    J Rheumatol; 2010 Jun; 37(6):1174-80. PubMed ID: 20436070
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease.
    Ahmadi-Simab K, Hellmich B, Gross WL.
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():44-8. PubMed ID: 16919010
    [Abstract] [Full Text] [Related]

  • 12. Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis.
    Cestelli V, Manfredi A, Sebastiani M, Praino E, Cannarile F, Giuggioli D, Ferri C.
    Mod Rheumatol; 2017 Jan; 27(1):110-114. PubMed ID: 27310203
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy with Bosentan and Sildenafil improves Raynaud's phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis.
    Bellando-Randone S, Lepri G, Bruni C, Blagojevic J, Radicati A, Cometi L, De Paulis A, Matucci-Cerinic M, Guiducci S.
    Clin Rheumatol; 2016 Jan; 35(1):127-32. PubMed ID: 26631100
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis.
    Cutolo M, Ruaro B, Pizzorni C, Ravera F, Smith V, Zampogna G, Paolino S, Seriolo B, Cimmino M, Sulli A.
    J Rheumatol; 2014 May; 41(5):881-6. PubMed ID: 24692525
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of the dual endothelin receptor antagonist bosentan on Raynaud's phenomenon secondary to systemic sclerosis: a double-blind prospective, randomized, placebo-controlled pilot study.
    Nguyen VA, Eisendle K, Gruber I, Hugl B, Reider D, Reider N.
    Rheumatology (Oxford); 2010 Mar; 49(3):583-7. PubMed ID: 20040526
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bosentan in pulmonary arterial hypertension secondary to scleroderma.
    Joglekar A, Tsai FS, McCloskey DA, Wilson JE, Seibold JR, Riley DJ.
    J Rheumatol; 2006 Jan; 33(1):61-8. PubMed ID: 16395751
    [Abstract] [Full Text] [Related]

  • 20. Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension.
    Iannone F, Riccardi MT, Guiducci S, Bizzoca R, Cinelli M, Matucci-Cerinic M, Lapadula G.
    Ann Rheum Dis; 2008 Aug; 67(8):1121-6. PubMed ID: 18029384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.